Seed VC · France

Sanofi Ventures

Active

What they invest in

We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing in early-stage transformational science and technology, when companies are too early to partner with or acquire.

Who they back

DeepTechHealthtechBiotechEvergreen fundSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip, saas_b2b, platform

Customer segments

Enterprise, Researchers, Providers, Payers, Government

Geography

US, Europe

Recent investments

  • Abcuro
  • AdvanCell
  • Atalanta Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

12 partners on file at Sanofi Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Sanofi Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Sanofi Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
France
Last known deal
Jan 2023
Portfolio last checked
Oct 6, 2026
Website
sanofiventures.com ↗

Other firms investing in DeepTech

See all investors

Is Sanofi Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Sanofi Ventures is one of them, and we'll tell you exactly where they sit in your top 100.